1. 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
by Erin D. Michos, Elizabeth Selvin, Jeffrey R. Misialek, John W. McEvoy, Chiadi E. Ndumele, Aaron R. Folsom, Christie M. Ballantyne, and Pamela L. Lutsey
J Am Heart Assoc
Volume 5(11):e003575
November 7, 2016
© 2016 Erin D. Michos et al.

2. Inclusion and exclusion criteria for participants for cross‐sectional analyses at ARIC visit 2 (1990–1992). 25(OH)D indicates 25‐hydroxyvitamin D; ARIC, Atherosclerosis Risk in Communities; CHD, coronary heart disease; eGFR, estimated glomerular f...
Inclusion and exclusion criteria for participants for cross‐sectional analyses at ARIC visit 2 (1990–1992). 25(OH)D indicates 25‐hydroxyvitamin D; ARIC, Atherosclerosis Risk in Communities; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; HF, heart failure; NT‐proBNP, N‐terminal pro–brain natriuretic peptide.
Erin D. Michos et al. J Am Heart Assoc 2016;5:e003575
© 2016 Erin D. Michos et al.

3. Inclusion and exclusion criteria for participants for prospective analyses from Atherosclerosis Risk in Communities visit 2 (1990–1992) to visit 4 (1996–1998).
Inclusion and exclusion criteria for participants for prospective analyses from Atherosclerosis Risk in Communities visit 2 (1990–1992) to visit 4 (1996–1998). NT‐proBNP indicates N‐terminal pro–brain natriuretic peptide.
Erin D. Michos et al. J Am Heart Assoc 2016;5:e003575
© 2016 Erin D. Michos et al.